Long-term effects of systemic gene therapy in a canine model of myotubular myopathy

Matthew Elverman Melissa Goddard 1 David Mack Jessica Snyder Michael Lawlor Hui Meng Alan Beggs 2 Ana Buj-Bello 3 Karine Poulard 1 Anthony Marsh Robert Grange 4 Valerie Kelly Martin Childers 5
1 INTEGRARE - Approches génétiques intégrées et nouvelles thérapies pour les maladies rares
2 Genomics Program and Division of Genetics
3 Généthon, Evry
4 LAM - Laboratoire d'Astrophysique de Marseille
5 Wake Forest University
Abstract : X-linked myotubular myopathy (XLMTM), a devastating pediatric disease caused by the absence of the protein myotubularin, results from mutations in the MTM1 gene. While there is no cure for XLMTM, we previously reported effects of MTM1 gene therapy using adeno-associated virus (AAV) vector on muscle weakness and pathology in MTM1-mutant dogs. Here, we followed 2 AAV-infused dogs over 4 years.
Keywords : adeno-associated virus canine gait gene therapy muscle myotubular myopathy neuromuscular disease
Document type :
Journal articles
Complete list of metadatas
https://hal-univ-evry.archives-ouvertes.fr/hal-02179358
Contributor : Melissa Goddard <>
Submitted on : Wednesday, July 10, 2019 - 4:40:55 PM
Last modification on : Wednesday, August 21, 2019 - 11:02:06 AM

Links full text

pubmedcentral

Identifiers

Collections

UNIV-EVRY | LAM | CNRS | INTEGRARE | INSU | UNIV-AMU | OSU-INSTITUT-PYTHEAS | UNIV-PARIS-SACLAY

Citation

Matthew Elverman, Melissa Goddard, David Mack, Jessica Snyder, Michael Lawlor, et al.. Long-term effects of systemic gene therapy in a canine model of myotubular myopathy. Muscle & nerve. Supplement., 2017, 56 (5), pp.943-953. ⟨10.1002/mus.25658⟩. ⟨hal-02179358⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

23

Université d'Évry-Val-d'Essonne

Boulevard François Mitterrand
91025 Evry Cedex
www.univ-evry.fr

Les gènes de la connaissance